TNNT2 and chronic kidney disease: In this cohort, hs-cTnT was detectable in 84% of CKD patients; higher levels were strongly and independently associated with left ventricular hypertrophy (LVH) and, to a lesser extent, with left ventricular systolic dysfunction, as assessed by echocardiography [70].